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Penilaian Aktiviti Anti-proliferatif dan Antimikrob                                      
Tiga Jenis Madu Trigona spp.  
 
 
ABSTRAK 
Trigona spp. yang dikenali sebagai Kelulut di Malaysia, adalah lebah kecil dari 
suku Meliponini. Madu lebah ini menghasilkan madu yang digunakan dalam 
penyembuhan luka, meningkatkan sistem immunisasi tubuh badan, membunuh 
bakteria, rawatan kahak bronkial, menghilangkan sakit tekak, batuk, dan demam. 
Dalam kajian ini, madu Trigona spp. telah diuji untuk menentukan aktiviti anti-
proliferatif terhadap sel kanser MCF-7, sel kanser servikal HeLa dan sel glial 
SVG menggunakan ujian MTT. Aktiviti antimikrobial madu Trigona spp. telah 
diuji dengan menentukan kepekatan penghalang minimum (MIC) terhadap E. coli, 
S. aureus dan C. albicans dengan menggunakan kaedah mikrodilution. Nilai 
kepekatan bakterisida minimum (MBC) atau nilai kepekatan fungisida minimum 
(MFC) ditentukan oleh sub kultiviti kandungan nutrien yang digunakan untuk 
ujian MIC pada agar nutrien dengan menggunakan gelang steril dan membuat 
caringan pada media untuk melihat pertumbuhan bakteria dengan inkubasi 37 ° C 
selama 24 jam. Tiada pertumbuhan E. coli dan S. aureus yang ditunjukkan oleh 
dari madu ialah MBC manakala MFC ditentukan oleh ketiadaan pertumbuhan C. 
albicans. Akhirnya, ujian pembunuhan masa ditentukan pada kepekatan 0.5 x 
MIC, 1 x MIC dan 2 x MIC dan diinkubasikan untuk jangka masa yang berlainan 
(0, 2, 4, 24 jam). Jumlah sel hidup (CFU / mL) bagi setiap sampel ditentukan 
menggunakan kaedah kiraan plat agar. Hasilnya, kedua-dua madu H. itama dan 
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madu T. laeviceps menunjukkan perencatan dalam pertumbuhan sel kanser 
payudara MCF-7 dan sel kanser servik HeLa. Walau bagaimanapun, madu T. 
laeviceps mempunyai aktiviti anti-proliferatif yang lebih baik pada sel MCF-7 
tetapi aktiviti anti-proliferatif yang lemah pada sel HeLa. Sebaliknya, madu H. 
itama menunjukkan aktiviti anti-proliferatif yang lebih baik pada sel HeLa tetapi 
lebih lemah pada sel sel MCF-7. Selain itu, madu Trigona spp. adalah tidak toksik 
kepada sel normal manakala toksik kepada sel kanser. Madu H. itama yang tidak 
dicairkan (kepekatan 100%) mempromosikan percambahan sel normal. Untuk 
aktiviti antimikrob, nilai MIC madu Trigona spp. terhadap E. coli berkisar 
3.125% hingga 6.25% manakala terhadap S. aureus berkisar 3.125% hingga 
12.5%. Selain itu, C. albicans menunjukkan kerentanan rendah terhadap semua 
jenis madu. Ujian masa membunuh menunjukkan aktiviti bakteria terhadap E.coli 
dan S. aureus. Madu lebah tanpa sengat menunjukkan pengurangan E.coli selepas 
24 jam manakala pengurangan S. aureus ditunjukkan selepas rawatan 2 jam. 
Aktiviti anti-proliferatif dan antimikrobium madu dikaitkan dengan kandungan 
fenol total mereka, aktiviti hidrogen peroksida, keasidan dan hyper-osmolarity 
madu. Kami membuat kesimpulan bahawa madu Trigona spp. menunjukkan 
kesan perencatan yang berlainan pada sel-sel kanser yang berbeza dan aktiviti 
antibakteria spektrum yang lebih luas tetapi lemah dalam aktiviti antikulat. Walau 
bagaimanapun, siasatan selanjutnya terhadap Trigona spp. mekanisme tindakan 
madu, dalam kajian vivo, dan kesan toksikologi diperlukan untuk menetapkan 
keselamatan mereka sebagai agen antikanker dan antimikrobial. 
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Evaluation of The Anti-proliferative and Antimicrobial Activities                  
of Three Types of Trigona spp. Honey 
 
 
ABSTRACT 
Trigona spp. known as Kelulut in Malaysia, was a small stingless bee from tribe 
Meliponini. This stingless bee produced honey which was used in wound healing, 
increase immune system, killing bacteria, treatment of bronchial phlegm, relieving 
sore throat, cough, and cold. In this study, the Trigona spp. honeys were tested to 
determine the anti-proliferative activity against MCF-7 breast cancer cell lines, 
HeLa cervical cancer cell and SVG normal glial cell using MTT assay. The 
antimicrobial activities of Trigona spp. honey were tested by determination of 
minimum inhibitory concentration (MIC) against E. coli, S. aureus and C. 
albicans using microdilution method. Then minimum bactericidal concentration 
(MBC) or minimum fungicidal concentration (MFC) value were determined by 
sub culturing the contents of nutrient broth used for MIC tests on nutrient agar 
using sterile wire loop and making a strike on the media to see bacteria growth 
after incubating at 37 °C for 24 hours. Absence of growth of E. coli and S. aureus 
were indicated the MBCs of the honeys while MFC were determined by absence 
growth of C. albicans. Lastly, the time kill assay were determined at 
concentrations of 0.5 x MIC, 1 x MIC and 2 x MIC and were incubated for varied 
time intervals (0, 2, 4, 24 hours). The number of living cells (CFU/mL) of each 
sample was determined using the agar plate count method. As the result, both H. 
itama honey and T. laeviceps honey were showed inhibition in the growth of 
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MCF-7 breast cancer cell line and HeLa cervical cancer cell lines. However, the 
T. laeviceps honey has better anti-proliferative activity on MCF-7 cell lines but 
weak anti-proliferative activity on HeLa cell line. In contrast, H. itama honey 
showed better anti-proliferative activity on HeLa cell line but much weaker on 
MCF-7 cell lines. Besides, Trigona spp. honeys were non-toxic to the normal cell 
line while toxic to the cancer cell line. The undiluted H. itama honey (100 % 
concentration) promoted normal cell proliferation. For antimicrobial activity, MIC 
values of the Trigona spp. honey against E. coli were ranged 3.125 % to 6.25 % 
while against S. aureus were ranged 3.125 % to 12.5 %. Besides, C. albicans 
showed low susceptibility to all types of honeys. Time kill assay showed that have 
bactericidal activity against E.coli and S. aureus. The stingless bee honey showed 
the reduction of E.coli after 24 hours while the reduction of S. aureus was showed 
after 2 hours of treatment.  The anti-proliferative and antimicrobial activities of 
the honey were correlated with their total phenols content, hydrogen peroxide 
activity, acidity and hyper-osmolarity of the honey. We concluded that the 
Trigona spp. honey showed varied inhibitory effects on different cancer cell lines 
and broader-spectrum antibacterial activity but weak in antifungal activity. 
However, further investigation of Trigona spp. honey mechanisms of action, in 
vivo studies, and toxicological effects will be necessary to establish their safety as 
anticancer and antimicrobial agents.  
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1 Background of study  
Stingless bee known as Kelulut in Malaysia is come from subfamily Meliponinae. 
Commonly stingless bees are important for pollination of crops and wild plants at South 
America, Australia, Asia and Africa (Garibaldi, 2013). This bee is different than honey 
bee (Apis) because do not have sting but release irritant chemical to defense from 
disrupter (David, 2006). Stingless bee consists of two tribes which are Trigona and 
Melipona. Variety of stingless bee species can be found in Malaysia including Trigona 
itama, Trigona thoracica, Trigona terminata, Trigona laeviceps, and Hypotrigona 
scintillans (Kelly et al., 2014).  
 
Stingless bee produce powerful honey that stored in clusters of small resin pots 
in their nest (Latifah et al., 2016).  The beneficial of the honey as medicinal and food 
for human health is well known worldwide. Usually, the honey is taken twice daily in 
the morning and at the night (Latifah et al., 2016). The stingless bee honey also used 
traditionally for anti-ageing, enhancing libido and immune system, killing bacteria, 
treatment of bronchial phlegm, and relieving sore throat, cough, and cold (Barakhbah, 
2007). Besides that, the honey also use as antiseptic to avoid infection on eyes and 
cutaneous injuries (Alejandro et al., 2014). This honey is believed to reduce 
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cardiovascular risk in both healthy patients and in those with potential risk factors 
(Pasupuleti et al., 2016).  
 
The pharmacological properties of the stingless bee honey included anti-
inflammatory, antioxidant, anti-ageing, and antibacterial properties (Latifah et al., 
2016). Based on Alejandro et al., (2014), anti-inflammatory properties of the honey are 
proved to treat muscle fatigue, sprains, injuries and mauls by dabbing the honey on 
affected areas. A lot of studies reported the Kelulut honey have antibacterial properties. 
According to DeMera and Angert, (2004), the honey showed antimicrobial activity 
against several different bacterial strains, including Bacillus cereus (Gram positive 
bacteria) and Pseudomonas aeruginosa (Gram negative bacteria), as well as against 
yeasts such as Candida albicans and Saccharomyces cerevisiae. The antibacterial 
properties of honey also possess wound healing activity (Boorn et al., 2010).  
 
Experiment on mice proved that the stingless bee honey can improve granulation 
tissue thickness and open wound size (Pasupuleti et al., 2016). In addition, strong 
antioxidant activities of the honey proved that the stingless bee honey has potential 
chemopreventive agents (Beretta et al., 2005). The stingless bee honey possesses 
moderate anticolon cancer activity due to caffeic acid ester that responsible as agent 
against colon cancer (Latifah et al., 2016).  
 
Although varies reports on the anticancer and antimicrobial effects of stingless 
bee honey are available, but the information on specific species of stingless bee honey 
such Itama and Laeviceps are lacking and further investigation is required. 
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1.2 Problem statement 
As the cancer becomes one of the life threatening diseases throughout the world, there 
are interest to develop a new anticancer drugs, which are more specific and less side 
effects than chemotherapeutic drugs. Chemotherapeutic treatment can cause side effects 
in short-term and also for the long term (Katrin, 2012). Besides, long-term use of 
chemotherapy can lead to drug resistance via several different mechanisms, such as gene 
mutation, DNA methylation and histone modification (Genevieve et al., 2014). 
 
While in pharmacological industries, resistance to antibiotics drugs by 
microorganisms has increased (Gislene et al., 2000). The emergence of antibiotic-
resistant bacteria has drawn major attention among healthcare and medical practitioners. 
According to Assegid et al., (2003), the drug resistance of bacteria and side effects of 
some pharmaceutical products give rise to an aversion to synthetic drugs. However, 
synthetic drugs are very expensive and the doubt on the safety of the drug arose among 
community. Synthetic drugs possess many negative effects like anxiety, allergic 
reactions, heart palpitations, kidney and renal failure, or may increase the risk of fatal 
diseases. 
 
Stingless bee honey is one of the natural bee products which have long been used 
as traditional medicine due its healing properties. Therefore, nature products like 
Trigona spp. honey will be the cheapest and safer alternative sources of anticancer and 
antimicrobial agents. 
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1.3 Significant of study  
This study is focusing on the anti-proliferative and antimicrobial activity Trigona spp. 
honey. The result of this research will prove the honey contain with active compounds 
that lead to the anti-proliferative and antimicrobial properties of the honey.  
 
Therefore, Trigona spp. honey may serve as natural product and further 
developed to be used in medical industries, cosmetic, household products, cleaning 
agents, sanitizers, dermatological product and other commercial values. In addition, 
Trigona spp. honey can be potential sources for developing new drugs and more 
effective anti-cancer and antimicrobial agents for future therapy. The new drugs based 
on natural product will be more save and reduce the risk of side effect. Besides that, the 
information that gained from this study is important to add more collection of database 
for future studies in Malaysia. 
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1.4 Objectives of study 
 
1.4.1 General objective 
To evaluate the anti-proliferative and antimicrobial activities of three types of Trigona 
spp. honey. 
 
1.4.2 Specific objectives 
a. To determine the anti-proliferative activity of three types of Trigona spp. honey on 
selected cancer cell lines. 
b. To determine the minimal inhibitory concentration (MIC) of three types of Trigona 
spp. honey against the microorganisms.  
c. To determine the time-related antimicrobial efficacy of three types of Trigona spp. 
honey. 
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CHAPTER 2 
 
 
LITERATURE REVIEW 
 
 
2.1 Stingless bees 
Bees are well known insects for their roles in pollination. These insects have 
approximately about 20,000 known species of bees in seven recognized biological 
families. Stingless bees (Figure 2.1) are one of the species of bees other than honey bee 
and bumblebee (bombini).  Stingless bees come from subfamily Meliponinae while the 
honey bees from subfamily Apinae, and both are grouped in the same family Apidae 
(Ewnetu et al., 2013). There are around 64 genera and 500 species of stingless bees that 
abundant in subtropical and tropical regions of the world such as Tropical America, 
Australia, Africa and Southeast Asia (Araujo et al., 2004).  
 
 
Figure 2.1: Stingless bee Trigona spp. (Jaymi, 2017). 
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Stingless bees are smaller in size than common honey bees. Besides, stingless 
bees are not harmful to humans as they have reduction of sting (Kyle et al., 2015). 
However, the stingless bee will defend their hives aggressively by biting, irritating, and 
crawling into the eyes or ears of the intruder. Furthermore, the bees also can produce a 
caustic liquid from their mouth and releasing unpleasant odors to annoy the predator 
(Zweden et al., 2011). Different with honey bees which make honey in vertical comb, 
the stingless bees hive (Figure 2.1.1) consists of thimble-sized oval shaped honey or 
pollen pots placed around the one cell thick brood area of the combs that are arranged 
horizontally (Assegid et al., 2003).  
 
Usually, the storage pots build of resinous cerumen in the ground or in the tree 
trunk (Yalemwork et al., 2013). Cerumen is similar to propolis which produced by the 
secretion of the stingless bee during construction of the hive (Simone-Finstrom and 
Spivak, 2010). Uses of cerumen are important to store the honey and to avoid insect 
attack as well as to ensure the sterile environment in the hive (Mohd Azri et al., 2016). 
Both groups make honey in perennial nests founded by a swarm of sterile workers and a 
queen, and colonies occasionally produce male bees.  
 
Meliponinae stingle are divided into two tribes, which are Trigona and Melipona 
based on taxonomic characteristics (Maria et al., 2006). These two tribes of Meliponinae 
are used in stingless bee keeping because can produce large amounts of honey. The 
Melipona species are restricted to central and south America whereas Trigona species 
occur in all the tropical continental regions (Amano et al., 2000).  
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There are nearly 150 species of Trigona bees in this world such as Trigona 
apicalis (T. apicalis), Trigona drescheri (T. drescheri), Trigona fuscibasis (T. 
fuscibasis), Trigona fuscobalteata (T. fuscobalteata), Trigona incisa (T. incisa), Trigona 
itama (T. itama), Trigona laeviceps (T. laeviceps), Trigona melina (T. melina), Trigona 
terminate (T. terminate) (Syafrizal et al., 2012). 
 
2.1.1 Trigona spp. honey 
Honey is a natural sweet substance used in the world. The honeybees suck the honey 
from nectar of flowers and then transform it by combining with specific substances of 
their own before store and leave in the honeycomb to ripen and mature (Alimentarius, 
2001). In some region especially in the tropics and subtropics, stingless bees honey is 
more popular than honey by typical honey bees. The stingless bee honey is primarily 
produced by Tetragonisca, Melipona, Scaptotrigona, Plebeia (in America), Meliponula 
(in Africa) and Tetragonula (in Asia) (Souza et al., 2006). 
 
In Malaysia, honey from these bees is known as Kelulut honey. This multifloral 
honey is stored in clusters of small resin pots near the extremities of their nests (Siok et 
al., 2014). The nectar collected by the stingless bee will undergo three different 
transformation processes before turning into honey in the cerumen pots (Mohd Azri et 
al., 2016). Firstly the physical of nectar is changed due to evaporation of water content 
in the nectar. Next, biological transformation occurs when fermentation process by yeast 
and bacteria which play a symbiotic role with the bee. Lastly, a chemical transformation 
take places by secretion the enzymes from the bee cephalic glands which hydrolyses the 
nectar’s sucrose into fructose and glucose (Menezes et al., 2013).  
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The honey that is produced by these stingless bees or Trigona spp. is viscous and 
darker than Apis spp. honey (Assegid et al., 2003). The dark colour of honey is impacted 
due to the abundant resin chemicals and hydrogen peroxide which makes the honey does 
not ferment in the nest. Most Trigona spp. honeys are oil-looking at the first glance and 
then turn to whitish paste after crystallization (Souza et al., 2006). According to Biluca 
and other researchers (2014), Trigona spp. honey has a distinct taste and aroma, more 
fluid in texture, and undergoes slow crystallization. Besides, the Trigona spp. honey also 
has a stronger acidic flavor (Garedew et al., 2013). Usually the pH value of the honey is 
around 3.2 to 4.9 (Assegid et al., 2003).  
 
Approximately one to two liters of honey can be yield from a colony of stingless 
bee (Assegid et al., 2003). The honeys are collected using disposable syringes and 
suction pump for more efficiently (Souza et al., 2006). The productions of stingless bee 
honey are controlled by environmental changes and by inappropriate management 
during harvest the honey or transfer the hive to other location (Villanueva et al., 2005).  
 
Thus the market price of stingless bee honey is sold at higher price than Apis 
honey mainly due to its rarity and low production of the honey. In addition, the honey 
has special medicinal value and the production costs are high because of its harvesting 
process (Heard and Dollin, 2000).  
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2.1.2 Uses of Trigona spp. honey 
Honey is a special gift from nature for human. Honey is highly valued as a food source 
and natural sweetener since the earliest times (Boorn et al., 2009). Human used honey 
started as early as the Stone Age (Jose et al., 2010). The ancient Chinese, Egyptians, 
Greeks, Assyrian and Romans make practical and effective use of different types of 
honey to treat diseases at that time (Pasupuleti et al., 2016).  Uses of honey are started as 
a drug and an ointment in 2100–2000 BC (Jose et al., 2010). Besides, the stingless bee 
honeys are used by Aboriginal people of northern Australia for cultural significance, 
playing a role in the social traditions and rituals of the people (Isaacs, 2000).  
 
Stingless bee honey is more powerful than honey from common bees in folk 
medicine due to “natural” cure for treating variety type of diseases (Vit, 2001).  
Therefore, honey has been used as traditional medicines, alone or by adding with other 
substances. The honeys are widely applied as traditional medicine in Central and South 
America, and Africa (Cortopassi-Laurino et al. 2006). This honey has been administered 
both topically and orally (Samrudhi et al., 2015). But some people do not eat the honey 
because of the strong sour taste (Assegid et al., 2003).  
 
Stingless bee honey which is also known as Kelulut honey is used traditionally 
by local people in Malaysia for anti-ageing, enhancing libido and immune system, 
killing bacteria, treatment of bronchial phlegm, and relieving sore throat, cough, and 
cold (Barakhbah, 2007). Usually the honey is taken twice daily, once in the morning and 
at night to heal sore throat, cough and cold. In Ethiopia, stingless honey also used 
traditionally to treat wounds, respiratory infections and diarrhea (Yalemwork et al., 
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2013). In addition, many panaceas are produced from the honey to treat stomach 
disturbance, tonsillitis, stomach and intestinal ulcers, disease of the mouth and mucus 
membrane, and as wound dressing (Assegid et al., 2003). These panaceas are applied by 
poor people in the rural area to treat these serious illnesses.  
 
The stingless bee honey plays an important role in Ayurvedic medicine to cure 
eye diseases, hiccups, thirst, blood vomiting, leprosy, asthma, diabetes, worm 
infestation, diarrhoea, obesity and healing wounds (Samrudhi et al., 2015). In addition, 
the Trigona spp. honey also applies as eyedropper to treat eyesight problems (Pasupuleti 
et al., 2016). Other than being used as sweetener, the honey is also used in treating 
glaucoma and cataracts (Jose et al., 2010).  
 
2.1.3 Chemical constituents of Trigona spp. honey 
Generally, the composition of honey is inconstant and variable based on the floral source 
where the bees collect raw material (Pasupuleti et al., 2016). Besides, external factors 
also give effect to the composition of honey, such as seasonal and environmental factors 
and processing (Jose et al., 2010). Furthermore, the composition of honey is influenced 
by processing, handling, and storage time (Bertoncelj et al., 2007). 
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Table 2.1: Physico-chemical properties of stingless bee honey 
                         (Souza et al., 2006). 
Physico-chemical properties of stingless bee honey 
Appearance Amber brown 
Moisture content 25.02 % 
pH 3.05–4.55 
Total reducing sugars 55.00–86.00% 
Glucose 8.20–30.98 % 
Fructose 31.11–40.20 % 
Sucrose 0.31- 1.26 % 
Electrical conductivity (mS/cm) 0.49–8.77 
HMF (mg/kg) 8.80–69.00 
Ash content (g/100 g) 0.01–0.12 
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Approximately 200 compounds are discovered consist in honey such as vitamins, 
enzymes, amino acids and minerals (Ramanauskiene et al., 2012). The major contents in 
honey are 15 % to 17 % of water and 80 % to 85 % of sugar (Bogdanov et al., 2008). 
The intense sweetness of honey arises from the very high content of two 
monosaccharaides, glucose and fructose with addition to about 25 different 
oligosaccharides (Sohaimy et al., 2015). The honey also consist organic acids, minerals 
and trace elements such as calcium, potassium, sodium, magnesium, phosphorus, 
sulphur, iron, zinc, copper and manganese (Pasupuleti et al., 2016). 
 
Honey also rich with various vitamins, including ascorbic acid (VitaminC), 
thiamine (Vitamin B1), pantothenic acid (Vitamin B5), riboflavin(Vitamin B2), nicotinic 
acid (Vitamin B3), pyridoxine (Vitamin B6), biotin (Vitamin B8), folic acid (Vitamin 
B9) and cyanocobal-amin (Vitamin B12) (Ciulu et al., 2011). 
 
Additionally, honey is rich with other active compounds that exert several 
biological activities such as antibacterial, hepatoprotective, anti-inflammatory, 
hypoglycemic, antioxidant, anti-proliferative, antitumor, antimetastatic, anticancer and 
antihypertensive effects (Omotayo et al., 2014). The antioxidant effects of stingless bee 
honey depend on the presence of flavonoids, phenolic acids, ascorbic acid, catalase, 
peroxidase, carotenoids, and the products of Maillard reactions (Khalil et al., 2011). 
Based on Beretta et al. (2005), the total phenolic content in honey is strongly correlated 
with its antioxidant activity. Furthermore, flavonoids are the main component in 
ameliorating oxidative stress that play important role in antioxidant activity (Pasupuleti 
et al., 2016).  
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Many studies have reported that there are a great variety of flavonoids and 
phenolic compounds that have been identified in honey including chrysin, kaempferol, 
quercetin, pinobanksin, pinocembrin, luteolin, apigenin, genistein, naringenin, 
hesperetin, p-coumaric acid, gallic acid, ellagic acid, ferulic acid, syringic acid, caffeic 
acid and vanillic acid (Meda et al., 2005, Bertoncelj, et al., 2007 and Kassim et al., 
2010). However, the total phenolic content of the honey are differs based on type of bee 
species, region, season and type of floral sources (Almeida da Silva et al., 2013). Honey 
also contains two important enzymes that play a major role in its biological activities 
which are bee-origin glucose oxidase and floral-origin catalase (Zainol et al., 2013). 
These enzymes are the key elements in regulating the level of peroxide activity in honey 
that is important in producing the antimicrobial activity of the honey (Kacaniova et al., 
2011). 
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Table 2.2: Molecular representation of Polyphenols found in the honey    
(Saravana and Mahitosh, 2009). 
 
Polyphenols 
Caffeic acid 
Caffeic acid 
phenyl ester 
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2.1.4 Previous study of Trigona spp. honey  
The majority of research has focused on honey of Apis mellifera, however attention has 
been paid to honey from stingless bees. Recently, the study according to 
pharmacological properties of the stingless bee honey from researcher all over the world 
has increased. Various pharmacological properties of the stingless bee honey have been 
reported and shared by researcher such as anti-inflammatory (Massaro et al., 2011), 
antioxidant (Siok et al., 2014; Bertoncelj et al., 2007), anticancer (Choudhari et al., 
2013), anti-diabetic (Adesoji and Oluwakemi, 2008), anti-ageing (Sabir et al., 2005), 
and antibacterial properties (Temaru et al., 2007, Boorn et al., 2009, Zainol et al., 2013). 
 
Numerous studies report on anticancer activity of stingless bee propolis but still 
lacking on stingless bee honey (Pasupuleti et al., 2016). Stingless bees honey from 
Trigona species showed strong antioxidant activities that related to the potential of 
anticancer activity of the honey (Latifah et al., 2016). The honey produce from stingless 
bee Tetragonula carbonaria have higher total antioxidant activity than that of the 
European floral honey (Oddo et al., 2008).  
 
From the study done by Yazan et al. (2016), stingless bee honey have potential 
as chemo-preventive agent by reducing the total number of aberrant crypts (AC), crypt 
multiplicity and aberrant crypt foci (AFC) in Sprague Dawley rats which induced with 
colorectal cancer. Furthermore, stingless bee honey showed a cytotoxicity effect on 
many types of cell lines (Kuatiawan et al., 2014). The cytotoxic of the honey on the cells 
are act as anti-proliferative or apoptotic (Porcza et al. 2016). Patricia and other 
researchers (2013) discovered the anti-proliferative action of pot honey 
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from Frieseomelitta, Melipona, Scaptotrigona, and Tetragonula on human ovarian 
cancer cell lines.  
 
Commonly, the antimicrobial activity of stingless bee honey is investigated by 
using the Kirby-Bauer antibiotic test, the agar dilution test, broth microdilution, and 
time-kill viability assays (Temaru et al., 2007, Boorn et al., 2009, Zainol et al., 2013). 
Kelulut honey has quantitatively poor but gave large zones of inhibition on agar 
diffusion assay, especially against S. aureus, indicating high antibacterial activity 
(Zainol et al., 2013). Honey of the stingless bees also produced the highest mean 
inhibition compared to white honey and yellow honey on all the standard and resistant 
strains (Yalemwork et al., 2013).  
 
In addition, Trigona laeviceps honey show antimicrobial activity against bacteria 
strain E. coli and S. aureus and the fungal strain Aspergillus niger, as well as two types 
of yeasts which are Auriobasidium pullulans and C. albicans (Chanchao, 2009). Data 
from both the agar and broth dilution methods indicated that stingless bee honey has 
broad-spectrum antibacterial activity but limited activity against Candida (Boorn et al., 
2009). The antibacterial effect of stingless bee honey is influenced by non-peroxide 
activity such as high sugar content and the acidity of the honey (Temaru et al., 2007).  
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2.2 Cancer 
Cancer can arise from a single cell which multiplies and divides clonally in an 
uncontrolled manner and made up of billion more cell cancers (Trosko, 2001). The 
abnormal proliferative of cells at any part of body can cause cancer cell at the tissues 
and organs eventually spreading throughout the body (Cooper, 2000).  
 
A group or lump of cells that grow abnormally is known as tumor and divided 
into two classes which are benign and malignant based on their different cellular 
characteristics (Paula et al., 2007). Usually benign tumor remains and grows slowly in 
its original location and does not invade other surrounding tissues (Cooper, 2000). Thus, 
this tumor is noncancerous and can be removed by surgery, but probably to recur again. 
However, malignant tumor can cause more changes in cell biology (Paula et al., 2007). 
This tumor can lead to uncontrolled and overgrowth of cells which cause damage to the 
cells and tissues of the body.  
 
Besides, the tumor cells can grow rapidly and easily spread around the body 
through circulatory or lymphatic systems, and attacked the surrounding cells (Cooper, 
2000). The movement of malignant tumor cells from the initial site to colonize other 
distant organs is known as metastasis which leads to cancer and difficult to treat 
(Patricia, 2016). Furthermore, the cancer cells do not die because the cells do not 
undergo programmed cell death which is known as apoptosis unlike normal cell 
(Graham, 2015). Thus, the cancer cells keep growing uncontrollably and invade 
neighbouring tissues.  
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2.2.1 Cancer statistics  
Nowadays there are more than 100 different types of cancers that invade almost any part 
of human body. Cancer is known by the type of cell that is initially affected (Graham, 
2015).  According to Paula et al. (2007), cancer was the leading cause of death amongst 
the global population after cardiovascular diseases. In 2013, about 14.1 million new 
cancer cases and 8.2 million deaths recorded worldwide (Linsey et al., 2015). In United 
State, one in 4 deaths is caused by cancer (Rebecca et al., 2013).  
 
In addition, rates of cancer of prostate, colorectal, female breast, and lung are 
multiple times higher in more developed regions than less developed countries. In less 
developed countries, common cancers that cause deaths are liver, stomach, and cervical 
cancers which are related to infection and they are detected at the last stage (Linsey et 
al., 2015).  
 
In Malaysia, cancer is also known as one of major health concerns due to the 
number of diseases that arise from cancer keep growing yearly (Gerard, 2002). It is 
estimated that the annual incidence of cancer is 30 000 and expected to increase follow 
the growing of aging and lifestyle of the population. The common cancer types that 
cause death in Malaysia population are lung, liver, breast, stomach, leukemia, colon, 
nasopharynx, cervix, lymphoid tissue and ovary (Gerard, 2002).  
 
Cancer is terrifying disease that affecting everyone regardless to gender and age. 
According to Gerard (2002), the most invasive cancers for males are lung, nasopharynx, 
stomach, urinary bladder, rectum, non-Hodgkin’s lymphoma, larynx, liver, colon and 
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esophagus. On the other hand, common cancers among female are including cervix, 
breast, ovary, lung, nasopharynx, esophagus, thyroid, colon, rectum and non-Hodgkin’s 
lymphoma.  
 
In 2009, almost half of the cancer cases were diagnosed in adults aged more than 
sixty five years (Robert, 2014). Based on growing numbers of older adults, the total 
number of cancers is expected to increase by 45 % from 2010 to 2030 (Smith et al., 
2009). However, the cancer does not only attack at older age but also can be found in 
children and also infant. Worldwide, approximately 150 in 1 million children are 
affected with cancer annually (Merenu et al., 2016). The estimated rate of pediatric 
malignancies is 77.4 per million children in Malaysia, whereby the range of age is less 
than fifteen years (Gerard, 2002).  
 
Usually, the cancer symptoms in children are unrealized at earlier stage (Roberta 
and Lesley, 2003). The leading cancer types among children are leukemia, tumors of the 
brain and spinal cord, lymphomas, neuroblastoma, gonadal and germ cell tumors, kidney 
tumors, soft tissue sarcomas and retinoblastomas (Gerard, 2002). Therefore, cancer is 
emerging as the fourth leading cause of death for children especially in Asia, Central and 
Middle East (Merenu et al., 2016).  
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2.2.2 Breast cancer 
Breast cancer is recorded as the major public health problem in women. Each year, 
approximately more than 40 000 women are dead caused by this malignant disease 
(Muhammad Al-hajj et al., 2003). This cancer can cause death because it can 
metastasize only within 3 years from the initial detection of the primary tumor to the 
lymph nodes and other distant organ (Britta et al., 2005). In 2008, about 1.38 million of 
breast cancer cases are estimated worldwide and 458 400 cases ended with deaths 
(Ahmedin et al., 2011). However, the number of the cases recorded all around the world 
is increased to 1.7 million cases and 521,900 deaths in 2012 (Lindsey et al., 2015). 
Usually, about half of the breast cancer cases and deaths are highly recorded in 
developing countries (Ahmedin et al., 2011). 
 
According to Zarghan and other researcher (2017), an individual has higher 
potential to get breast cancer if any family member has history of breast cancer which is 
caused by gene mutations in the BRCA1 and BRCA2 genes. Besides, one of risks to 
have breast cancer is coming from reproductive factors such as a long menstrual history, 
a woman who have never gave birth, use of hormone therapy or oral contraceptives, and 
have the first child at late age (Hulka and Moorman, 2001). Other potential risk factors 
include overweight or obese, weight gain after 18 years old, physical inactivity, and 
alcohol consumption (Lindsey et al., 2015).  
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Therefore, early diagnosis by mammographic screening and the implementation 
of systemic adjuvant therapy is important to prevent metastasis of the breast cancer 
(Britta et al., 2005). Furthermore, early signs and symptoms of the breast cancer can be 
found through clinical breast examination (Anderson et al., 2010). Chemotherapy can 
help to increase fifteen years of survival rate by 10 % for women who are younger than 
50 years old (Britta et al., 2005). 
 
2.2.3 Cervical cancer  
Cervical cancer is another silent killer disease among women although the cancer 
develops very slowly. Cervical cancers mostly are squamous cell carcinomas that grow 
in the squamous (flattened) epithelial cells that line the cervix (Gunjan and Keyur, 
2012). The common symptoms of cervical cancer like abnormal vaginal bleeding after 
sexual contact and continuous vaginal discharge (Ashlesha and Neha, 2016). In year 
2012, approximately 527,600 new cases of cervical cancer and 265,700 deaths are 
estimated worldwide (Lindsey et al., 2015).  
 
Thus, this cancer is stated as one of the most common diagnosed cancer and the 
fourth leading cause of cancer death in females worldwide (Ahmaden et al., 2011). 
Usually this cancer cases are highest recorded in sub-Saharan Africa, Latin America and 
the Caribbean, and Melanesia but lowest in Western Asia, Australia, New Zealand, and 
Northern America (Lindsey et al., 2015). In Malaysia, about 12.9 % of female with 
cancers are diagnosed with cervical cancer (Zaridah, 2014). 
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About 90 % of cervical cancer is caused by Human papillomavirus (HPV) 
infection that is easily spread through sexual intercourse (Gunjan and Keyur, 2012). 
Besides, other common risk factors include smoking, tough framework for women, 
intake of conception prevention pills, having sex at a youthful age, and numerous sexual 
accomplices. Apart from that, women with numerous pregnancies also risk with higher 
potential of cervical cancer (Dooley, 2016).  
 
Therefore, HPV vaccine is important to prevent the cervical cancer and it is 
recommended for girls start from age eleven to twelve years old (Zaridah, 2014). In 
addition, early detection of cervical cancer is also important by using pap smears screen, 
colposcopy, and cone biopsy (Gunjan and Keyur, 2012). Normally, the cervical cancer 
still can be treated with cisplatin in chemotherapy, trachelectomy and also hysterectomy 
(Ashlesha and Neha, 2016). The treatment of the cancer is determined based on the stage 
of the cancer, size and shape of the tumor, age of the patient and also desire to have 
children in the future (Smith, 2010).  
 
2.2.4 Causes of cancer 
Based on Paula and other researchers (2007), development of cancer is classified by two 
factors which are exogenous and endogenous. Exogenous factor of cancer development 
includes nutritional habits, socio-economic status, lifestyle, physical agents, chemical 
compounds and biological agents. Endogenous factors of the cancers mean it is caused 
by immune system damage and inflammation, uncertain aetiology, genetic makeup, age, 
endocrine balance and physiological condition.  
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Unhealthy lifestyle of an individual can turn to be the major factor that leads to 
the cancer. In 2015, approximately 25 % of 1,658,370 cancer cases are attributed from 
poor nutrition which based on the food preparation and preservative, physical inactivity, 
overweight, and obesity (Stacey et al., 2015). According to Giovanni and Franco (2013), 
obesity and overweight can cause cancer of endometrial, esophageal adenocarcinoma, 
colorectal, postmenopausal breast, prostate, and kidney.  
 
Besides, excess alcohol consumption and smoking of tobacco are also 
responsible in result of cancer (Weisburger, 1999). Estimated 171,000 deaths of cancer 
patients are caused just by tobacco smoking alone (Stacey et al., 2015). Commonly, 
smoking and drinking alcohol heavily will be factor for cancer of lung, oral cavity, 
esophagus, larynx, pharynx, esophagus, stomach, rectum, liver, and breast (Stacey et 
al., 2015).  
 
Some cancers are developed from infection of biological agents such as 
Helicobacter pylori, Epstein Barr virus, human T lymphotropic viruses I and II, human 
papilloma virus and the hepatitis B virus (Paula et al., 2007). For example, 
bacterium H. pylori causes stomach cancer and gastric lymphoma, hepatitis C virus 
(HCV) can causes cirrhosis and liver cancer, while human papillomavirus (HPV) can 
lead to cervical cancer (Stacey et al., 2015).  
In addition, cancer also can be induced by other carcinogenic agents including 
chemical,   ultraviolet radiation exposure, exposed to ionizing radiation in the form of 
gamma rays from outer space and from global distribution of manmade gamma and X-
radiation from nuclear weapons testing and nuclear reactor accidents (Stacey et al., 
